PaulAGoepfertMD
Infectious Disease • Birmingham, ALProfessor, Medicine, University of Alabama School of Medicine
Dr. Goepfert is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
619 19th Street South
Birmingham, AL 35233Phone(205) 934-6600
- Is this information wrong?
Education & Training
University of Alabama Medical CenterFellowship, Infectious Disease, 1994 - 1997
University of Alabama Medical CenterResidency, Internal Medicine, 1991 - 1994
Baylor College of MedicineClass of 1991
Certifications & Licensure
AL State Medical License 1992 - 2021
TX State Medical License 1992 - 1997- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Clinical Trials
- Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine When Increasing the Number of Injections Compared to the Standard Regimen in Immunocompromised Subjects With HIV Infection Start of enrollment: 2014 Apr 01Peck, A.,Brown, A.,Walker, D.,Overton, E.T.,Quinn, J.,Franz, J.A.,Spitz, T.,Sauter, W.
- A Phase I/II, Two-Staged, Single-Center, Randomized, Double-Blind, Antibody Titer Study to Assess Immunogenicity and Safety of FluMist® Intranasal Influenza Vaccine Administered With and Without a TLR-3 Agonist, Ampligen®. Start of enrollment: 2012 Apr 01Overton, E.T.,Goepfert, P.A.,Strayer, D.R.
- A Phase 2a Clinical Trial to Evaluate the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of pGA2/JS7 DNA and MVA/HIV62, in Healthy, HIV Uninfected Vaccinia-naive Adult Participants Start of enrollment: 2009 Jan 01Goepfert, P.A.
- Evaluation of HIV-Specific CD8+ T-Cell Responses and Escape Mutations as Explanations for the Observed Differences in Disease Progression Conferred by HLA Class I Alleles Start of enrollment: 2002 Dec 01Goepfert, P.
- Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus M. Anthony Moody and Paul Goepfert
- Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine Paul Goepfert and Kathy Mngadi
- A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of pGA2/JS7 DNA Vaccine and Recombinant Modified Vaccinia Ankara/HIV62 Vaccine in Healthy, HIV-1-Uninfected Adult Participants Goepfert, P.,Hay, C.M.
- Join now to see all
Publications & Presentations
PubMed
- Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection.Jacob K Files, Sushma Boppana, Mildred D Perez, Sanghita Sarkar, Kelsey E Lowman, Kai Qin, Sarah Sterrett, Eric Carlin, Anju Bansal, Steffanie Sabbaj, Dustin M. Long, ...> ;Journal of Clinical Investigation. 2021 Jan 4
- Annals On Call - A Primer on COVID-19 VaccinesRobert M. Centor, Paul A. Goepfert> ;Annals of Internal Medicine. 2020 Nov 24
- SARS-CoV-2-specific peripheral T follicular helper cells correlate with neutralizing antibodies and increase during convalescence.Sushma Boppana, Kai Qin, Jacob K Files, Ronnie M. Russell, Regina Stoltz, Frederic Bibollet-Ruche, Anju Bansal, Nathan Erdmann, Beatrice H. Hahn, Paul A. Goepfert> ;medRxiv. 2020 Oct 12
- Join now to see all
Press Mentions
Johnson & Johnson's COVID-19 Vaccine Results Are Better Than They May SoundJanuary 30, 2021 16:33- COVID-19 Vaccine Facts and FiguresJanuary 28, 2021 17:44
- NIH’s Strategy to Assess Moderna’s COVID-19 Vaccine at Half Dose Has Significant Stumbling Blocks for Evidence Collection and AnalysisJanuary 24, 2021 11:37
- Join now to see all
Grant Support
- CTL And HIV Polymorphisms In Heterosexual TransmissionNational Institute Of Allergy And Infectious Diseases2010–2012
- HIV-1 Cryptic Epitopes: Implications For Vaccine DesignNational Institute Of Allergy And Infectious Diseases2009–2011
- ClinicalNational Institute Of Allergy And Infectious Diseases2008–2011
- HIV-1 Suppression By MHC Class I Restricted CD8 T CellsNational Institute Of Allergy And Infectious Diseases2007–2008
- Alabama/Zambia HIV Vaccine Clinical Trials Unit (HVTU)National Institute Of Allergy And Infectious Diseases2004–2006
- CD8+ T Cell Cytokine Production In HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases2002–2005
- CD8+ T Cell Cytokine Production In HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases2001
- Human Foamy Virus Structural ProteinsNational Institute Of Allergy And Infectious Diseases1996–2000
Hospital Affiliations
Birmingham Veterans Affairs Medical CenterBirmingham, Alabama
University of Alabama HospitalBirmingham, Alabama
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
